Filing Flows › Agape ATP (ATPC) › Q4 2025
Agape ATP (ATPC) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Apr 13, 2026
Agape ATP (ATPC) reported revenue of $399K for the fourth quarter 2025 (Q4 2025), +11% from a year earlier and +8% from the quarter before. Operating margin was -325.2%, net loss $376K (94.2% of revenue).
Agape ATP, Q4 2025: revenue $399K (+11% year over year), operating margin -325.2%, net loss $376K, operating cash flow −$208K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $399K | +8% | +11% |
| Operating profit | −$1.3M | — | — |
| Net earnings | −$376K | — | — |
| Operating cash flow | −$208K | — | — |
What changed
Revenue was $399K in Q4 2025, up 11% year over year and up 8% from the previous quarter. Product Health Therapies was the largest line at 65% of revenue.
Gross margin was 58.6%, up 9.1 points from Q4 2024. Operating costs exceeded revenue by $1.3M, an operating margin of -325.2%. Operating expenses grew 49% against revenue growth of 11%. The fastest-growing cost line was Other operating costs (+97%). The quarter ended with a net loss of $376K, narrower than the previous quarter's $595K loss. Non-operating items added $923K, -246% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$208K. Non-cash charges added back $3K of depreciation and amortization. Working capital and other items added $165K. Capital expenditures of $0K exceeded it, leaving free cash flow of −$209K.
Questions
What was Agape ATP's revenue in the fourth quarter 2025?
Agape ATP (ATPC) reported revenue of $399K for the fourth quarter 2025 (Q4 2025), +11% from a year earlier and +8% from the quarter before.
Was Agape ATP profitable in the fourth quarter 2025?
Operating loss was $1.3M (-325.2% of revenue) and net loss $376K.
Source: Agape ATP 10-K on SEC EDGAR.